Medicinal products
INDIVIDUAL AUTO-INJECTOR KIT FOR PROTECTION AGAINST CHEMICAL WARFARE AGENTS IZAS 05
Atropine Auto-Injector,
2 mg/2 mL, solution for injection (Atropini sulfas)
Pralidoxime + Atropine Autoinjector,
600 mg/2 mL + 2 mg/2 mL, solution for injection
(Pralidoximi chloridum + Atropini sulfas)
Diazepam Auto-Injector,
10 mg/2 mL, solution for injection (Diazepamum)
Shelf life
2 years.
Special precautions for storage
Do not store above 25°C. Protect against freezing.
Rpw – available on prescription only, containing narcotics as specified in separate regulations
Reference: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560671/
IZAS-05 is a set of three auto-injectors (Atropine Auto-Injector, Pralidoxime + Atropine Auto-Injector, Diazepam Auto-Injector) intended for use in the event of poisoning by nerve chemical warfare agents to relieve the symptoms and counteract the effects of poisoning.
„The product is not intended to be marketed as defined in the Pharmaceutical Law of 6 September 2001 (Journal of Laws – current version)”.
PAIN RELIEF MORPHINE AUTO-INJECTOR
The Pain-Relief Morphine Auto-Injector is an auto-injector designed for intramuscular use in the event of pain from extensive body injuries.
2 mL of solution contains 20 mg of morphine sulphate (Morphini Sulfas)
Shelf life
2 years.
Special precautions for storage
Do not store above 25°C. Protect against freezing.
Rpw – available on prescription only, containing narcotics as specified in separate regulations
side effects
Warning: Invalid argument supplied for foreach() in /raviwww2/wp-content/themes/ravimed/templates/oferta.php on line 34
If you experience any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the Department for Monitoring of Adverse Reactions of Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products:
181C, Jerozolimskie Av., 02-222 Warsaw, phone: 22 49-21-301, fax: 22 49-21-309,
e-mail: ndl@urpl.gov.pl
Adverse reactions can also be reported to the Marketing Authorisation Holder:
Ravimed Sp. z o.o., 54 Polna Street, 05-119 Łajski
mail: adr_ravimed(a)ravimed.com.pl
Phone: (22) 782 21 67 (22) 506 56 56
Fax: (22) 782 21 67
By reporting side effects you can help provide more information on the safety of this medicine.
“The product is not intended to be marketed as defined in the Pharmaceutical Law of 6 September 2001 (Journal of Laws – current version)”.
